Filter by:
Filter by:
All Research
Biotechnology
Emerging Technology
Institute for Progress
Ruxandra Teslo

Dr. Ruxandra Teslo holds a PhD in Genomics from the Sanger Institute at the University of Cambridge. She previously co-led the Clinical Trial Abundance initiative.

  • All Research
  • Biotechnology
  • Emerging Technology
Biotechnology
Proxy Praxis: How Surrogate Endpoints Can Speed Drug Development
A new series from the Institute for Progress
Read the full report
December 23rd 2025
  |  
By Ruxandra Teslo
Emerging Technology
Biotech’s Lost Archive
How to fuel AI by unlocking the FDA’s knowledge of biotech failures
Read the full report
August 11th 2025
  |  
By Ruxandra Teslo
Biotechnology
The Case for Clinical Trial Abundance
A series of short papers outlining reform possibilities for America's clinical trials
Read the full report
December 18th 2024
  |  
By Willy Chertman and Ruxandra Teslo